Crescina Development has been a time-tested dermato-cosmetic treatment for topical application focused on addressing hair thinning, activating the natural hair growth and not just another product against hair loss aimed at slowing down or preventing the detachment of the hairs already present on the scalp. Crescina Transdermic HFSC Development is designed to prevent and address thinning caused by normal (non-pathological) factors and for cases where the quantity and quality of hair gradually decrease due to reduced activity of the hair follicles.
The Crescina Transdermic HFSC Complete Treatment for Development and Against Hair Loss Man 200 combines in one package two formulations, Crescina Transdermic Development HFSC and Crescina Transdermic Against Hair Loss. It is a specially designed male formula for the initial stages of thinning and for advanced hair loss and is available in a package with 10+10 ampoules (one month treatment). The ampoules contain 3.5 ml of formulation.
The patented formulation, thanks to the Transdermal Technology of Labo, allows the active molecules to penetrate the hair system not only through the hair follicles but also transdermally, i.e., through the layers of the scalp (epidermis and dermis). Thanks to their low molecular weight and the presence of 3 absorption enhancers, the penetration and delivery of the functional active ingredients is facilitated. The treatment achieves a comprehensive action on all hair structures and its composition promotes the natural growth of hair and acts against hair loss in healthy and semi-dormant follicles.
*EFFECTIVE IN 100% OF THE SUBJECTS WHO UNDERWENT TESTING:
Result after 4 months in the context of an in vivo clinical/instrumental double-blind randomized controlled study with placebo in 46 individuals (of whom 23 were administered the Crescina HFSC formulation and the remaining 23 the placebo). The men who underwent testing had thinning grades II, III, III vertex and IV on the Hamilton-Norwood scale. Positive results were recorded in all individuals, specifically developing from +7 to +41 new hairs at a minimum to +41 at a maximum in an electronically counted area of 1.8 cm². The results of the test are statistically significant. DEVELOPMENT of 6,300 NEW HAIRS on average after 4 months of treatment with Crescina HFSC 100%. Instrumental analysis conducted with phototrichogram.
Dermatologically tested formula.
48 
